PharmaLedger Project Review
Below we recap the past three years of the PharmaLedger Project, which concludes at the end of December 2022.
The PharmaLedger Project concludes at the end of 2022, and we’d like to thank everyone who has joined us on this journey. Working together, we have created the groundwork for blockchain solutions and innovation in healthcare that benefits the entire ecosystem, from manufacturers to patients.
Watch our project wrap-up video below for a deep dive into what we’ve achieved and where we’re going next.
To conclude the project, let’s take a look back at our achievements and project milestones over the past three years.
The PharmaLedger Project Journey
PharmaLedger was born out of an idea from Novartis some years before 2020, when the company was interested in researching blockchain technology in healthcare. From an idea, it grew to become the PharmaLedger project sponsored by the Innovative Health Initiative (IHI), formerly known as the Innovative Medicines Initiative (IMI), and the European Federation of Pharmaceutical Industries and Associations (EFPIA) under the Horizon 2020 programme.
PharmaLedger’s goal from the very beginning has been to provide an open-source, trusted platform that supports the design and adoption of blockchain-enabled healthcare solutions to accelerate medical innovation. Our 30 partners and the many new partnerships formed along the way have helped to build a Digital Trust Ecosystem (DTE) in healthcare.
Continue the Journey with us and Stay in Touch!
The PharmaLedger Project may be ending, but our work is not finished. Wee are evolving and continuing our efforts through the not-for-profit PharmaLedger Association (PLA). Before we continue our look back, we would like to invite you to sign up to the new PLA newsletter in order to stay in touch with us in the future.
If you’d like to get involved by becoming a member or would like to keep up with our developments, sign up for the PLA newsletter below.
*Please Note: if you are subscribed to the PharmaLedger Project newsletter, your subscription will not automatically transfer to the new PLA newsletter. We will no longer be posting articles or updates on this website, or sending PharmaLedger project newsletters.
What is a Digital Trust Ecosystem?
Foundational to our vision of a better healthcare system for all, a DTE is an interdependent group of actors (enterprises, people, things) sharing standardised digital platforms to achieve a mutually beneficial purpose, underpinned with cryptographic trust (i.e., blockchain). Creating value and mutual benefit for all stakeholders involved in healthcare is one of the key goals of the PharmaLedger Project, which will continue with PLA.
PharmaLedger Use Cases
Our use cases cover many different areas of healthcare, with many overlapping and building on each other to bring ecosystem-wide solutions that benefit all involved in the Digital Trust Ecosystem (DTE). PharmaLedger’s use cases cover three domains: supply chain, health data and clinical trials.
You can watch all of our use case explainer videos in one place: our PharmaLedger Explainer Videos YouTube playlist below.
PharmaLedger Timeline
2020 – Year 1
From Design to Development
January 2020
- PharmaLedger Kick-Off Event in Prague, Czech Republic
- Press Release #1
June 2020
- PharmaLedger Establishes Eight Use Cases
- Press Release #2
July 2020
- First Explainer Video Release: Blockchain Enabled Healthcare Consortium
- Launch of PharmaLedger Website: pharmaledger.eu
- Launch PharmaLedger Social Channels: YouTube, Twitter and LinkedIn
- First Internal Webinar: From Design to Development
- What is blockchain? Explainer Video
September 2020
- First Partner for Dissemination – The European Blockchain Convention (EBC)
- PharmaLedger Advisory Board Established
- First PharmaLedger Newsletter
November 2020
- #1 Open Webinar: Supply Chain Use Cases
December 2020
- First PharmaLedger Plenary Meeting
- Press Release #3
2021 – Year 2
Development and Deployment of Solutions | Patient Engagement and Technology Education
January 2021
- Launch of PharmaLedger’s Facebook Page
February 2021
- Official PharmaLedger Presentation Released
- #2 Open Webinar: Health Data & Clinical Trial Use Cases
- Forbes Featured Article
March 2021
- SCOPE Summit Event Participation
- DIA 2021 Spotlight Session
- Second Partner for Dissemination: LogiPharma
June 2021
- Conducted HCP Focus Group
July 2021
- Mid-Project Plenary Meeting
- Published the #Hashing it Out: Blockchain Terms Explained Series
August 2021
October 2021
- PharmaLedger Synergies/Roadmap Workshop in Toledo, Spain
- EPF Congress 2021 Event
- ePI Patient Workshop Series
November 2021
- IMI Mid-Project Review Meeting
- #3 Open Webinar: Making ePI a Reality
December 2021
- Press Release #4
- EBC Event Participation
- Deployed six nodes in 2021
2022 – Year 3
Validation and Sustainability | Implementation and Transition to the Post-Project Governance
February 2022
- Clinical Trial eRecruitment Use Case Explainer Video
- SCOPE Summit Event Participation
March 2022
- PharmaLedger General Assembly & Plenary Meeting
April 2022
- LogiPharma Event Participation
June 2022
- #4 Open Webinar: Building a Digital Trust Ecosystem
- Open Consultation Event – Shifting the Paradigm for Patient Recruitment
- PharmaLedger & GLIEF Press Release: Enabling Trusted Digital Identity
- EPF Congress 2022 Event Participation
- EBC 2022 Event Participation
July 2022
August 2022
- Detecting Falsified Medicines Use Case Explainer Video
- electronic Consent (eConsent) Use Case Explainer Video
September 2022
October 2022
- Introduction of the PharmaLedger Association (PLA)
- Launch of PLA Website: pharmaledger.org
- PharmaLedger Last Mile Workshop in Lisbon, Portugal
November 2022
- #5 Open Webinar: Blockchain-Powered Clinical Trials
- PharmaLedger’s Closing Event & Expo in Madrid, Spain
PharmaLedger Project Milestones
_______________________________
PharmaLedger Firsts
– First open source collaboration in the healthcare industry
– First home for Open Source Software (OSS) in healthcare-regulated tech | OSS allows many different IT systems to work together and encourages collaboration among various stakeholders, such as governmental organisations, patient organisations, healthcare manufacturers, healthcare workers and especially patients.)
– First single portal for patients |The unified PharmaLedger App is the first single portal for patients in the industry, where a patient won’t have to use various apps from other companies or medicinal brands.
– Patient-first mentality | We are working alongside many patient organisations, such as the European Forum for Good Clinical Practice (EFGCP) to make sure that the patient’s perspective is taken into consideration during the development of all use cases.
PharmaLedger Project Final Events Highlights
PharmaLedger Last Mile Event at Lisbon
PharmaLedger’s Celebration Final Event in Madrid
PharmaLedger Project Final Thoughts
“After over 4 years of project planning and execution, PharmaLedger comes to a successful close. The PharmaLedger Association is mandated to carry on the journey towards real digital transformation and value creation for stakeholders. We are thankful for the passion, persistence, and patience of all our consortium members and partners. It will still take a lot of work to scale the solutions, but the investment is already reaping rewards.” – Marco Cuomo, PharmaLedger Industry Project Leader, Novartis
“The endorsement of the future governance and operational design is the culmination of years of hard work and passionate leadership by the consortium members. It is proof that we can and will deliver on the promise of blockchain enabled healthcare in the future. I feel very fortunate to be a part of this journey and can’t wait to make it a reality with productive solutions that bring value to patients!” – Daniel Fritz, Executive Director of PLA, PharmaLedger Association (PLA)
“Collaborative innovation is leading PharmaLedger to higher chances of achieving greater impact to society and in healthcare. We are moving to become a real-world Healthcare Digital Trust Ecosystem. Opening-up to new external partners is exciting! I hope that people and organisations will join the PharmaLedger Association on this journey to collaborate under common values and future opportunities that will improve other lives.” – Xenia Beltran, LiFesTech, Universidad Politécnica de Madrid
“The PLA endorsement further solidifies PharmaLedger’s initiatives as a sustainable solution for the responsible digitalisation of our global healthcare system. We look forward to the collaboration opportunities the PLA will create as we continue to work together as one team, focused on improving patient access to vital, lifesaving information.” – Michael Ritter, Head Serialisation & Digital Enabling, Takeda
We would like to thank everyone again for all your efforts in the PharmaLedger Project, and we are proud to have been able to gather and reflect on all of our achievements over the past three years. We hope that this isn’t our final goodbye and that you’ll continue the journey with us in the next chapter of PLA by becoming a part of our Digital Trust Ecosystem (DTE).
————————
If you have any questions, feel free to reach out to us via the new PLA website. You can also find a list of FAQs in case you’re wondering what we are doing next and how you can become involved in the evolution of the project.